< Back to front page Text size +

Today's Globe: ocean water safety, soft drink sales, fast-track drug

Posted by Elizabeth Cooney September 11, 2008 06:56 AM

Beachgoers will be told more about whether it's safe to go in the water under a court settlement between environmentalists and the EPA.

Soft drinks accounted for less than a quarter of the beverages sold in schools last year, demonstrating that a voluntary transition toward healthier drinks is working, the beverage industry said yesterday (second item).

Proteon Therapeutics Inc., a privately held Waltham biopharmaceutical company, said it has received fast-track designation for a drug candidate from the Food and Drug Administration. PRT-201 is being investigated for its ability to improve vascular access in patients currently on or being prepared for hemodialysis.

Email this article

Invalid email address
Invalid email address

Sending your article

Your article has been sent.

add your comment
Required
Required (will not be published)

This blogger might want to review your comment before posting it.

about white coat notes We post updates every weekday about the region's hospitals, labs and medical schools – covering everything from the latest research findings to what's on the minds of the innovative doctors, nurses and scientists who work here. Send news items and tips to whitecoat@globe.com

Contributors

blogger

Elizabeth Cooney is a former health reporter for the Worcester Telegram & Gazette, where she also was a business reporter and an editor. Earlier in her career, she edited medical books and journals at Little, Brown, and worked for Boston magazine.

Boston Globe Health and Science staff:

archives